RESEARCH ETHICS

Sham surgery controls: intracerebral grafting of fetal tissue for Parkinson’s disease and proposed criteria for use of sham surgery controls

R L Albin

Correspondence to:
Correspondence to:
Dr R L Albin, Department of Neurology, University of Michigan, 4412D Kresge III, 200 Zina Pitcher Place, Ann Arbor, MI, 48109–0585, USA;
ralbin{at}umich.edu

Sham surgery is a controversial and rarely used component of randomised clinical trials evaluating surgical interventions. The recent use of sham surgery in trials evaluating efficacy of intracerebral fetal tissue grafts in Parkinson’s disease has highlighted the ethical concerns associated with sham surgery controls. Macklin, and Dekkers and Boer argue vigorously against use of sham surgery controls. Macklin presents a broad argument against sham surgery controls while Dekkers and Boer present a narrower argument that sham surgery is unnecessary in the specific setting of fetal tissue engraftment for Parkinson’s disease. I defend sham surgery controls against both these criticisms. Appropriate clinical trial design, sometimes including sham surgery, is needed to ensure that false positive trial results do not occur and endanger public safety. Results of a completed trial of fetal tissue grafting for Parkinson’s disease are used to illustrate the potential benefits of, and problems associated with, sham surgery controls. Sham surgery controls, however, should be employed only when absolutely necessary. I suggest criteria for appropriate use of sham surgery controls.

Keywords: Parkinson’s disease; sham surgery controls; intracerebral grafting of fetal tissue

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Rascol, O. (2005). Assessing the risk of a necessary harm: Placebo surgery in Parkinson disease. Neurology 65: 982-983 [Full Text]  
• Kim, S. Y. H., Frank, S., Holloway, R., Zimmerman, C., Wilson, R., Kieburtz, K. (2005). Science and Ethics of Sham Surgery: A Survey of Parkinson Disease Clinical Researchers. Arch Neurol 62: 1357-1360 [Abstract] [Full Text]  
• Moreira, T., Palladino, P. (2005). Between truth and hope: on Parkinson's disease, neurotransplantation and the production of the 'self'. History of the Human Sciences 18: 55-82 [Abstract]  
• Hartling, L., McAlister, F. A., Rowe, B. H., Ezekowitz, J., Friesen, C., Klassen, T. P. (2005). Challenges in Systematic Reviews of Therapeutic Devices and Procedures. ANN INTERN MED 142: 1100-1111 [Abstract] [Full Text]  
• Albin, R L (2005). Sham surgery controls are mitigated trolleys. J. Med. Ethics 31: 149-152 [Abstract] [Full Text]  
• Miller, F. G, Kaptchuk, T. J (2004). Sham procedures and the ethics of clinical trials. JRSM 97: 576-578 [Full Text]  
• (2003). Sham surgery can be ethical and safe. J. Neurol. Neurosurg. Psychiatry 74: 202-202 [Full Text]